(CHH) Choice Hotels International - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1699051066
Stock: Lodging, Hotels, Franchising
Total Rating 41
Risk 84
Buy Signal -1.18
| Risk 5d forecast | |
|---|---|
| Volatility | 28.3% |
| Relative Tail Risk | -2.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.85 |
| Alpha | -35.75 |
| Character TTM | |
|---|---|
| Beta | 0.541 |
| Beta Downside | 1.017 |
| Drawdowns 3y | |
|---|---|
| Max DD | 45.50% |
| CAGR/Max DD | -0.08 |
EPS (Earnings per Share)
Revenue
Description: CHH Choice Hotels International March 04, 2026
Choice Hotels International (CHH) is a hotel franchisor, operating primarily in the United States and internationally. The company generates revenue by licensing its brands to independent hotel owners, a common business model in the hospitality sector.
CHH manages two segments: Hotel Franchising & Management and Corporate & Other. Its extensive brand portfolio includes economy, midscale, and upscale properties, such as Comfort Inn, Quality, and Cambria Hotels, catering to diverse traveler needs.
Founded in 1939 and headquartered in North Bethesda, Maryland, CHH is a long-standing player in the Hotels, Resorts & Cruise Lines sub-industry. Further research on platforms like ValueRay can provide deeper insights into CHHs financial performance and market position.
Headlines to watch out for
- Franchise fee growth drives revenue expansion
- Hotel development pipeline impacts future earnings
- Travel demand fluctuations affect occupancy rates
- Interest rate changes influence hotel investment
- Regulatory shifts in hospitality sector pose risks
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 369.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.09 > 0.02 and ΔFCF/TA 2.41 > 1.0 |
| NWC/Revenue: -3.84% < 20% (prev -7.80%; Δ 3.96% < -1%) |
| CFO/TA 0.09 > 3% & CFO 270.4m > Net Income 369.9m |
| Net Debt (2.09b) to EBITDA (659.3m): 3.16 < 3 |
| Current Ratio: 0.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (46.5m) vs 12m ago -2.55% < -2% |
| Gross Margin: 51.01% > 18% (prev 0.50%; Δ 5.05k% > 0.5%) |
| Asset Turnover: 58.61% > 50% (prev 62.63%; Δ -4.02% > 0%) |
| Interest Coverage Ratio: 6.01 > 6 (EBITDA TTM 659.3m / Interest Expense TTM 91.1m) |
Altman Z'' 4.69
| A: -0.02 (Total Current Assets 406.0m - Total Current Liabilities 467.3m) / Total Assets 2.92b |
| B: 0.79 (Retained Earnings 2.32b / Total Assets 2.92b) |
| C: 0.20 (EBIT TTM 548.0m / Avg Total Assets 2.72b) |
| D: 0.85 (Book Value of Equity 2.31b / Total Liabilities 2.74b) |
| Altman-Z'' Score: 4.69 = AA |
Beneish M -3.15
| DSRI: 0.80 (Receivables 207.5m/257.6m, Revenue 1.60b/1.58b) |
| GMI: 0.98 (GM 51.01% / 50.19%) |
| AQI: 1.03 (AQ_t 0.61 / AQ_t-1 0.59) |
| SGI: 1.01 (Revenue 1.60b / 1.58b) |
| TATA: 0.03 (NI 369.9m - CFO 270.4m) / TA 2.92b) |
| Beneish M-Score: -3.15 (Cap -4..+1) = AA |
What is the price of CHH shares?
As of March 22, 2026, the stock is trading at USD 97.63 with a total of 696,525 shares traded.
Over the past week, the price has changed by +2.27%, over one month by -11.41%, over three months by +1.11% and over the past year by -24.15%.
Over the past week, the price has changed by +2.27%, over one month by -11.41%, over three months by +1.11% and over the past year by -24.15%.
Is CHH a buy, sell or hold?
Choice Hotels International has received a consensus analysts rating of 3.27.
Therefor, it is recommend to hold CHH.
- StrongBuy: 3
- Buy: 1
- Hold: 9
- Sell: 1
- StrongSell: 1
What are the forecasts/targets for the CHH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 111.8 | 14.5% |
| Analysts Target Price | 111.8 | 14.5% |
CHH Fundamental Data Overview March 20, 2026
P/E Trailing = 12.5987
P/E Forward = 12.8535
P/S = 4.6967
P/B = 24.6892
P/EG = 1.8634
Revenue TTM = 1.60b USD
EBIT TTM = 548.0m USD
EBITDA TTM = 659.3m USD
Long Term Debt = 1.91b USD (from longTermDebt, last quarter)
Short Term Debt = 8.36m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.09b USD (from netDebt column, last quarter)
Enterprise Value = 6.69b USD (4.61b + Debt 2.13b - CCE 45.0m)
Interest Coverage Ratio = 6.01 (Ebit TTM 548.0m / Interest Expense TTM 91.1m)
EV/FCF = 24.74x (Enterprise Value 6.69b / FCF TTM 270.4m)
FCF Yield = 4.04% (FCF TTM 270.4m / Enterprise Value 6.69b)
FCF Margin = 16.94% (FCF TTM 270.4m / Revenue TTM 1.60b)
Net Margin = 23.17% (Net Income TTM 369.9m / Revenue TTM 1.60b)
Gross Margin = 51.01% ((Revenue TTM 1.60b - Cost of Revenue TTM 782.3m) / Revenue TTM)
Gross Margin QoQ = 46.03% (prev 53.49%)
Tobins Q-Ratio = 2.29 (Enterprise Value 6.69b / Total Assets 2.92b)
Interest Expense / Debt = 1.11% (Interest Expense 23.7m / Debt 2.13b)
Taxrate = 17.94% (13.9m / 77.6m)
NOPAT = 449.7m (EBIT 548.0m * (1 - 17.94%))
Current Ratio = 0.87 (Total Current Assets 406.0m / Total Current Liabilities 467.3m)
Debt / Equity = 11.76 (Debt 2.13b / totalStockholderEquity, last quarter 181.2m)
Debt / EBITDA = 3.16 (Net Debt 2.09b / EBITDA 659.3m)
Debt / FCF = 7.71 (Net Debt 2.09b / FCF TTM 270.4m)
Total Stockholder Equity = 60.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.58% (Net Income 369.9m / Total Assets 2.92b)
RoE = 614.4% (Net Income TTM 369.9m / Total Stockholder Equity 60.2m)
RoCE = 27.87% (EBIT 548.0m / Capital Employed (Equity 60.2m + L.T.Debt 1.91b))
RoIC = 22.94% (NOPAT 449.7m / Invested Capital 1.96b)
WACC = 5.70% (E(4.61b)/V(6.74b) * Re(7.91%) + D(2.13b)/V(6.74b) * Rd(1.11%) * (1-Tc(0.18)))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF] Terminal Value 83.72% ; FCFF base≈231.7m ; Y1≈184.7m ; Y5≈124.2m
[DCF] Fair Price = 37.73 (EV 3.82b - Net Debt 2.09b = Equity 1.73b / Shares 46.0m; r=5.90% [WACC]; 5y FCF grow -24.27% → 2.90% )
EPS Correlation: 57.50 | EPS CAGR: 12.46% | SUE: 0.45 | # QB: 0
Revenue Correlation: 45.38 | Revenue CAGR: 11.69% | SUE: 1.23 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.94 | Chg7d=-0.022 | Chg30d=-0.033 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=7.20 | Chg7d=-0.064 | Chg30d=+0.067 | Revisions Net=+1 | Growth EPS=+3.7% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=7.74 | Chg7d=-0.007 | Chg30d=+0.162 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: -0.14 (3 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.0% (Discount Rate 7.9% - Earnings Yield 7.9%)
[Growth] Growth Spread = +0.7% (Analyst 0.7% - Implied 0.0%)
P/E Forward = 12.8535
P/S = 4.6967
P/B = 24.6892
P/EG = 1.8634
Revenue TTM = 1.60b USD
EBIT TTM = 548.0m USD
EBITDA TTM = 659.3m USD
Long Term Debt = 1.91b USD (from longTermDebt, last quarter)
Short Term Debt = 8.36m USD (from shortTermDebt, last quarter)
Debt = 2.13b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.09b USD (from netDebt column, last quarter)
Enterprise Value = 6.69b USD (4.61b + Debt 2.13b - CCE 45.0m)
Interest Coverage Ratio = 6.01 (Ebit TTM 548.0m / Interest Expense TTM 91.1m)
EV/FCF = 24.74x (Enterprise Value 6.69b / FCF TTM 270.4m)
FCF Yield = 4.04% (FCF TTM 270.4m / Enterprise Value 6.69b)
FCF Margin = 16.94% (FCF TTM 270.4m / Revenue TTM 1.60b)
Net Margin = 23.17% (Net Income TTM 369.9m / Revenue TTM 1.60b)
Gross Margin = 51.01% ((Revenue TTM 1.60b - Cost of Revenue TTM 782.3m) / Revenue TTM)
Gross Margin QoQ = 46.03% (prev 53.49%)
Tobins Q-Ratio = 2.29 (Enterprise Value 6.69b / Total Assets 2.92b)
Interest Expense / Debt = 1.11% (Interest Expense 23.7m / Debt 2.13b)
Taxrate = 17.94% (13.9m / 77.6m)
NOPAT = 449.7m (EBIT 548.0m * (1 - 17.94%))
Current Ratio = 0.87 (Total Current Assets 406.0m / Total Current Liabilities 467.3m)
Debt / Equity = 11.76 (Debt 2.13b / totalStockholderEquity, last quarter 181.2m)
Debt / EBITDA = 3.16 (Net Debt 2.09b / EBITDA 659.3m)
Debt / FCF = 7.71 (Net Debt 2.09b / FCF TTM 270.4m)
Total Stockholder Equity = 60.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 13.58% (Net Income 369.9m / Total Assets 2.92b)
RoE = 614.4% (Net Income TTM 369.9m / Total Stockholder Equity 60.2m)
RoCE = 27.87% (EBIT 548.0m / Capital Employed (Equity 60.2m + L.T.Debt 1.91b))
RoIC = 22.94% (NOPAT 449.7m / Invested Capital 1.96b)
WACC = 5.70% (E(4.61b)/V(6.74b) * Re(7.91%) + D(2.13b)/V(6.74b) * Rd(1.11%) * (1-Tc(0.18)))
Discount Rate = 7.91% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -3.14%
[DCF] Terminal Value 83.72% ; FCFF base≈231.7m ; Y1≈184.7m ; Y5≈124.2m
[DCF] Fair Price = 37.73 (EV 3.82b - Net Debt 2.09b = Equity 1.73b / Shares 46.0m; r=5.90% [WACC]; 5y FCF grow -24.27% → 2.90% )
EPS Correlation: 57.50 | EPS CAGR: 12.46% | SUE: 0.45 | # QB: 0
Revenue Correlation: 45.38 | Revenue CAGR: 11.69% | SUE: 1.23 | # QB: 2
EPS next Quarter (2026-06-30): EPS=1.94 | Chg7d=-0.022 | Chg30d=-0.033 | Revisions Net=-1 | Analysts=11
EPS current Year (2026-12-31): EPS=7.20 | Chg7d=-0.064 | Chg30d=+0.067 | Revisions Net=+1 | Growth EPS=+3.7% | Growth Revenue=+0.9%
EPS next Year (2027-12-31): EPS=7.74 | Chg7d=-0.007 | Chg30d=+0.162 | Revisions Net=+5 | Growth EPS=+7.5% | Growth Revenue=+3.7%
[Analyst] Revisions Ratio: -0.14 (3 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 0.0% (Discount Rate 7.9% - Earnings Yield 7.9%)
[Growth] Growth Spread = +0.7% (Analyst 0.7% - Implied 0.0%)